Skip to content

Study on the efficacy and safety of cycpofol in infant patients undergoing cochlear implantation

Study on the efficacy and safety of cycpofol in infant patients undergoing cochlear implantation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067354
Enrollment
Unknown
Registered
2023-01-05
Start date
2023-01-16
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical anesthesia

Interventions

Group 1:cyprofol of 0.6 mg/kg
Group 2:cyprofol of 0.7 mg/kg
Group 3: cyprofol of 0.8 mg/kg

Sponsors

The 980th Hospital of Joint Logistics Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Years

Inclusion criteria

Inclusion criteria: The patients who underwent cochlear implantation under general anesthesia were I-II according to ASA grade, the age was less than 12 years old, and the liver and kidney function was normal.

Exclusion criteria

Exclusion criteria: Congenital heart disease, acute asthma attack, abnormal blood system function, allergy to narcotic drugs, abnormal psychological behavior and mental and intellectual development, severe deformity of the inner ear, interruption or absence of auditory nerve, family members refused.

Design outcomes

Primary

MeasureTime frame
90% Effective Dose of Cyprofol;

Secondary

MeasureTime frame
Heart Rate;blood presure;Pulse oxygen saturation;the lowest value of BIS;Awakening time;postoperative emergence and delirium assessment using PAEDS scale;pain assessment using FLACC scale score in the PACU;Arterial blood gas analysis;

Countries

China

Contacts

Public ContactWu Yu

The 980th Hospital of Joint Logistics Support Force

vwuyuv@163.com+86 186 3348 7638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026